Dapagliflozin 5 mg (Generic)

Dapagliflozin 5 mg (Generic) is a prescription medicine belonging to the class of Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitors, designed to improve glycemic control in adults with type 2 diabetes mellitus. It works by reducing the reabsorption of glucose in the kidneys, leading to increased glucose excretion in urine and lower blood sugar levels.

Beyond blood sugar management, Dapagliflozin may also support weight reduction and help lower blood pressure. In some cases, it is prescribed to reduce the risk of hospitalization for heart failure and to improve kidney outcomes in patients with chronic kidney disease.

It is generally taken once daily, with or without food, as directed by a healthcare professional. Dapagliflozin is usually used alongside a healthy diet, exercise, and sometimes in combination with other diabetes medications.

Important Note: This medicine is not recommended for type 1 diabetes or diabetic ketoacidosis. Patients should follow medical advice closely and report any unusual symptoms such as urinary tract infections, dehydration, or excessive urination.